Skip to content

Bio-Techne TECH Asset Impairment Restructuring Charge

Asset Impairment Restructuring Charge at other companies

Xylem logo
XylemXYL
$500K0.0%
Xylem logo
XylemXYL
$31M+47.6%
Advanced Energy Industries logo
Advanced Energy IndustriesAEIS
$2.6M+117%
Howmet Aerospace logo
Howmet AerospaceHWM
-$93M-2,225%
Smurfit Kappa Group logo
Smurfit Kappa GroupSW
$54M+260%
Jones Lang LaSalle logo
Jones Lang LaSalleJLL
$5.3M-73.1%

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$9.07B-11.8%
Enterprise value$9.15B-13.6%
P/E60.6×+13.6×
P/S7.5×-1.0×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept tech:AssetImpairmentRestructuringCharge.

The official record: Bio-Techne’s 10-K, filed August 22, 2025, on SEC EDGAR. View the filing →

Ask your AI about Bio-Techne's asset impairment restructuring charge.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Techne's asset impairment restructuring charge?
Bio-Techne (TECH) reported asset impairment restructuring charge of $11.35M in Q2 2025.
How has Bio-Techne's asset impairment restructuring charge changed year-over-year?
Bio-Techne's asset impairment restructuring charge increased by 330.9% year-over-year, from $2.63M to $11.35M.
What does asset impairment restructuring charge mean?
This represents non-cash charges taken when the carrying value of an asset exceeds its recoverable amount, or costs associated with reorganizing business operations. It indicates a write-down of value or a strategic shift in the cost base.